Differential efficacy of lymphocyte- and monocyte-selective pretreatment with a type 4 phosphodiesterase inhibitor on antigen-driven proliferation and cytokine gene expression. [electronic resource]
Producer: 19970219Description: 28-37 p. digitalISSN:- 0091-6749
- 3',5'-Cyclic-AMP Phosphodiesterases
- Allergens -- pharmacology
- Antigens -- pharmacology
- Cells, Cultured
- Cyclic AMP -- metabolism
- Cyclic Nucleotide Phosphodiesterases, Type 4
- Cytokines -- biosynthesis
- Gene Expression -- drug effects
- Humans
- Leukocytes, Mononuclear -- drug effects
- Lymphocyte Activation -- drug effects
- Lymphocytes -- drug effects
- Phosphodiesterase Inhibitors -- pharmacology
- Phosphoric Diester Hydrolases -- drug effects
- Plant Proteins -- pharmacology
- Pyrrolidinones -- pharmacology
- Receptors, Cell Surface -- metabolism
- Rolipram
- Tetanus Toxoid -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.